What the documents showed
By the 1950s there was evidence in the literature that sugar consumption was associated with coronary heart disease. The question of what in the diet caused heart disease was genuinely open, and the two leading candidates were fat and sugar.
In 1965 the Sugar Research Foundation, the industry's trade body, funded its first project on coronary heart disease. It was not an experiment. It was a review of the existing literature, and it was published in the New England Journal of Medicine, one of the most authoritative places a review could appear. Its conclusion was that fat and cholesterol were the dietary causes of heart disease, and it discounted the evidence implicating sucrose.
In 2016 Cristin Kearns, Laura Schmidt and Stanton Glantz published an analysis of the Foundation's internal documents in JAMA Internal Medicine. What the files established was not that the review's conclusions had been dictated, which would be a stronger and less provable claim. It was more specific, and in some ways more instructive:
- the Foundation set the review's objective
- it supplied articles for inclusion
- it received drafts
And the published review disclosed none of this.
The authors' broader finding was that the industry sponsored a programme of research through the 1960s and 1970s that succeeded in casting doubt on the hazards of sucrose while directing attention to fat.
Wikimedia Commons — Uwe Hermann, CC BY-SA 3.0
Why the mechanism matters more than the conclusion
It is tempting to read this as a case of a corporation buying a false answer. That framing is not quite right, and getting it right is the point of the entry.
Fat and cholesterol genuinely were implicated in heart disease. The 1965 review was not a fabrication in the manner of a forged document; it was a review of real literature reaching a conclusion that a great many unpaid researchers also held. What the funder did was narrower and harder to see: it chose which question got asked, chose some of what went into the answer, and watched the drafts — and none of that appeared on the paper.
That is the thing worth understanding about manufactured doubt. It rarely requires anyone to lie. It requires control over framing, selection and emphasis, exercised early, by someone whose involvement the reader cannot see. A reader of the 1965 review had no way to weigh it correctly, because the one fact that would have told them how to weigh it was missing.
The consequence
The practical effect is the part that resists measurement, and it should be stated with appropriate hedging.
American dietary advice turned decisively against fat for several decades. Food manufacturers reformulated towards low-fat products, which frequently meant more added sugar. Whether and how much the Foundation's programme contributed to that turn is not something the internal documents can settle; the shift had many causes, including researchers with no industry money who argued the fat case on its merits for their whole careers.
What the documents do establish is that the industry was trying to produce that outcome, was spending money on it in 1965, and placed a sponsored review in a leading journal without saying it was sponsored. The intent is documented. The magnitude of the effect is an estimate.
It was not one review
A single sponsored review would be a small story. The follow-up work is what makes this a programme.
In 2017 Kearns, with Dorie Apollonio and Glantz, published a second documentary analysis in PLOS Biology, this time concerning industry-sponsored animal research. The internal files concerned a study of germ-free rodents examining whether sucrose was linked to raised blood lipids and to cancer — research the industry had funded, and which had produced results unhelpful to it.
The pattern the documents describe is the other half of the same method. The first case is about shaping what gets published. This one is about what happens to sponsored research whose results run the wrong way, and the answer in the files is that the work did not reach the literature.
Taken together the two analyses describe a research programme with a filter at both ends: influence over the framing of what is commissioned, and discretion over whether an inconvenient result is ever seen. Neither step requires falsifying a measurement, which is why neither step looks like misconduct in any individual paper.
Why this one is in the archive
Most entries here concern a claim that something was concealed. This is a case where the concealment is proven out of the concealing party's own filing cabinet, by named researchers, in a peer-reviewed journal, with the underlying documents publicly archived and readable by anyone.
That makes it useful as a calibration point, in two directions.
The reason this case is known in detail is that the documents survived and someone went through them — the same method Glantz had earlier applied to the tobacco industry's files. Where no comparable archive exists, the absence of a case like this one is not evidence that nothing happened. It is the ordinary condition, and it is why so much of this archive consists of allegations rather than findings.
But the second direction matters just as much, and it cuts the other way. When the filing cabinet does open, the finding it supports tends to be narrower and more mechanical than the one people expected. Not a bought lie — a bought question. Not scientists paid to say something false, but a funder choosing which comparison got made and declining to mention that it had. Anyone reasoning about what is likely to be true in the cases where no documents exist should calibrate on that, rather than on the more dramatic thing the documents did not show.